OneSavings Bank plc : Director/PDMR Shareholding

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
30
OneSavings Bank plc : Director/PDMR Shareholding

LEI: 213800WTQKOQI8ELD692

OneSavings Bank plc (the Company)

Notification of Transactions of Persons Discharging Managerial Responsibilities (PDMRs)

The Company notifies the grant of options over ordinary shares of £0.01 each of the Company to PDMRs at a price of £3.1454 each relating to the 2017 3 Year Sharesave Scheme.

Name Number of Options Granted
PDMRs
Jens Bech 2,861
Richard Davis 2,861
Jason Elphick 1,144
Richard Wilson 2,289

The following disclosures are made in accordance with Article 19 of the EU Market Abuse Regulation 596/2014.

  1 - Details of the person discharging managerial responsibilities / person closely associated

Name of natural person Jens Bech  

2 - Reason for the notification

Position/status Group Commercial Director
  
Initial notification/amendment Initial Notification  

3 - Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Full name of the entity OneSavings Bank plc
  
Legal Entity Identifier code 213800WTQKOQI8ELD692

4 - Details of the transaction(s)

  Transaction(s) summary table

  Date of Transaction Financial Instrument Identification Code Place of Transaction Currency
  22 September 2017 Ordinary shares of £0.01 each GB00BM7S7K96 Outside a trading venue GBP - British Pound
  Nature of Transaction:   Grant of options   Price Volume Total
£3.1454 2,861 £8,998.99
Aggregated £3.1454 2,861 £8,998.99
         

  1 - Details of the person discharging managerial responsibilities / person closely associated

Name of natural person Richard Davis  

2 - Reason for the notification

Position/status Chief Information Officer
  
Initial notification/amendment Initial Notification  

3 - Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Full name of the entity OneSavings Bank plc
  
Legal Entity Identifier code 213800WTQKOQI8ELD692

4 - Details of the transaction(s)

  Transaction(s) summary table

  Date of Transaction Financial Instrument Identification Code Place of Transaction Currency
  22 September 2017 Ordinary shares of £0.01 each GB00BM7S7K96 Outside a trading venue GBP - British Pound
  Nature of Transaction:   Grant of options   Price Volume Total
£3.1454 2,861 £8,998.99
Aggregated £3.1454 2,861 £8,998.99
         

  1 - Details of the person discharging managerial responsibilities / person closely associated

Name of natural person Jason Elphick  

2 - Reason for the notification

Position/status Group General Counsel and Company Secretary
  
Initial notification/amendment Initial Notification  

3 - Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Full name of the entity OneSavings Bank plc
  
Legal Entity Identifier code 213800WTQKOQI8ELD692

4 - Details of the transaction(s)

  Transaction(s) summary table

  Date of Transaction Financial Instrument Identification Code Place of Transaction Currency
  22 September 2017 Ordinary shares of £0.01 each GB00BM7S7K96 Outside a trading venue GBP - British Pound
  Nature of Transaction:   Grant of options   Price Volume Total
£3.1454 1,144 £3,598.34
Aggregated £3.1454 1,144 £3,598.34
         

  1 - Details of the person discharging managerial responsibilities / person closely associated

Name of natural person Richard Wilson  

2 - Reason for the notification

Position/status Group Chief Credit Officer
  
Initial notification/amendment Initial Notification  

3 - Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Full name of the entity OneSavings Bank plc
  
Legal Entity Identifier code 213800WTQKOQI8ELD692

4 - Details of the transaction(s)

  Transaction(s) summary table

  Date of Transaction Financial Instrument Identification Code Place of Transaction Currency
  22 September 2017 Ordinary shares of £0.01 each GB00BM7S7K96 Outside a trading venue GBP - British Pound
  Nature of Transaction:   Grant of options   Price Volume Total
£3.1454 2,289 £7,199.82
Aggregated £3.1454 2,289 £7,199.82
         

Enquiries:

OneSavings Bank plc Alastair Pate, Group Head of Investor Relations  t: 01634 838 973

Brunswick                                                        Robin Wrench / Simone Selzer                                        t:  020 7404 5959

Notes to Editors

About OneSavings Bank plc

OneSavings Bank plc ('OSB') began trading as a bank on 1 February 2011 and was admitted to the main market of the London Stock Exchange in June 2014 (OSB.L). OSB joined the FTSE 250 index in June 2015. OSB is a specialist lending and retail savings group authorised by the Prudential Regulation Authority, part of the Bank of England, and regulated by the Financial Conduct Authority and Prudential Regulation Authority.

OSB primarily targets underserved market sub-sectors that offer high growth potential and attractive risk-adjusted returns in which it can take a leading position and where it has established expertise, platforms and capabilities.  These include private rented sector Buy-to-Let, commercial and semi-commercial mortgages, residential development finance, bespoke and specialist residential lending and secured funding lines. OSB originates organically through specialist brokers and independent financial advisers.  It is differentiated through its use of high skilled, bespoke underwriting and efficient operating model.

OSB is predominantly funded by retail savings originated through the long established Kent Reliance name, which includes online and postal channels, as well as a network of branches in the South East of England. Diversification of funding is currently provided by access to a securitisation programme; and the Funding for Lending Scheme and Term Funding Scheme, which OSB joined in 2014 and 2016, respectively.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Melrose Fire Station Reaches Steel Topping Milestone

Updated Category News Views 4

Metal and Milestones: A New Era for Melrose Rolling into Melrose, Massachusetts, there's some serious action kicking off with the new Fire Engine 2 Station reaching a steel topping milestone. This phase isn't just about slapping on another beam; it's the crescendo of diligent teamwork from all the hands involved—from CTA Construction Managers to the clout of Ironworkers...

Continue Reading
Fuse Oncology Showcases New iRT Workflow at ASTRO

Updated Category News Views 4

Revolutionizing Charge Capture in Oncology Fuse Oncology's latest showcase at the ASTRO 2026 Annual Meeting isn't just about flashy presentations—it's looking to change how radiation oncology departments handle complex workflows. If you've ever delved into the maze of oncology billing, you know it's rife with opportunities for errors and inefficiencies. Skip one charge,...

Continue Reading
IASO's FUCASO Shows Robust Results in 2026 Study

Updated Category News Views 7

IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...

Continue Reading
Accuray, Samsung Push Boundaries with Imaging Deal

Updated Category News Views 4

In a move that's got the healthcare industry buzzing, Accuray Incorporated (NASDAQ: ARAY) announced its partnership with Samsung NeuroLogica to supercharge the CyberKnife® System. This isn't just another collaboration; it's a strategic pivot to advance imaging capabilities, marrying Samsung's volumetric innovations with Accuray's established precision in robotic...

Continue Reading
DKS Facing Class Action Over Stock Slump Allegations

Updated Category News Views 3

A Burst Bubble at DICK'S Sporting Goods Grit your teeth and hang on—DICK'S Sporting Goods has stumbled, and investors are supposed to just weather the storm. From September 8, 2025, through August 24, 2026, if you held DICK'S shares, you've got some explaining to do, or at least you better start reading the fine print. Take note, folks: the deadline to file for lead...

Continue Reading
Synagro Technologies Faces Lawsuit Over Unpaid Expenses

Updated Category News Views 6

Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...

Continue Reading
AI Memory Growth Pushes Limits at GMIF2026 Summit

Updated Category News Views 4

The Memory and Storage Race in the AI Era The 5th GMIF2026 Innovation Summit wrapped up in Shenzhen, and boy, was it a heavyweight bout. You could practically feel the tension in the room as industry giants sparred over the future of memory and storage in AI. This wasn't just another trade show pow-wow; this was a strategic chess match over where AI infrastructure is...

Continue Reading
Salveo Home Care Faces Class Action Over Labor Violations

Updated Category News Views 5

Another Company Lands in Hot Water Alright, it looks like Salveo Home Care is in the spotlight for all the wrong reasons. The home care provider—which should have been minding its P's and Q's—is now facing a class action suit. Why, you ask? Well, for allegedly skimping on wages and dodging legal obligations that leave their employees hanging dry. The Allegations are...

Continue Reading
Quay Shines in 2026 Prescription Sunglasses Lineup

Updated Category News Views 5

Spotlight on Quay: A Fashion-Forward Prescription Glasses that make you look good and actually correct your vision? That's the holy grail right there. Consumer365 just put Quay front and center in their 2026 rundown of the best prescription sunglasses out there. Let's break this down and see what's got folks buzzing. Diving into Style and Substance Now, if you're like me,...

Continue Reading
Leo Cancer Care's Upright Radiotherapy Milestone

Updated Category News Views 4

Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...

Continue Reading

Top 5 Most Recently Viewed Articles

Vaccinex Unveils Efficacy Insights for Pepinemab in Alzheimer’s Study

Updated Category News Views 71

Vaccinex Provides Update on Pepinemab Study for Alzheimer’s Disease ROCHESTER, N.Y. — Vaccinex, Inc. (NASDAQ: VCNX), a forward-thinking biotechnology firm, is making significant strides in the treatment of Alzheimer's disease (AD) and cancer. The company is focused on a unique approach through the inhibition of Semaphorin 4D (SEMA4D). Recently, it was announced that...

Continue Reading
Legal Inquiry into Netflix, Inc. (NFLX) Attracts Investor Attention

Updated Category News Views 287

Understanding the Investigation into Netflix, Inc. Recently, the law firm Robbins Geller Rudman & Dowd LLP has initiated a formal investigation into Netflix, Inc. (NASDAQ: NFLX). This inquiry primarily focuses on potential violations of U.S. federal securities laws that may have occurred within the company. The Implications for Investors This investigation comes at a...

Continue Reading
Norway's Wealth Fund Expands Portfolio with London Investment

Updated Category News Views 221

Norway's Sovereign Wealth Fund Takes Bold Step in London Norway's sovereign wealth fund, expertly managed by Norges Bank Investment Management, has recently made headlines with its strategic acquisition of a 25% stake in a notable portfolio of office and retail properties located in London's prestigious Mayfair district. Significant Investment in a Prime Location This...

Continue Reading
Exagen Inc. Announces New Biomarkers and Financial Success

Updated Category News Views 291

Exagen Inc. Introduces Groundbreaking Biomarkers for Autoimmune Diseases Innovative testing aims to enhance patient diagnosis and care Exagen Inc. (Nasdaq: XGN), a pioneering company in autoimmune testing, has achieved a significant milestone by receiving conditional approval from the New York State Department of Health for its advanced assays to diagnose systemic lupus...

Continue Reading
Pacaso's Financial Growth in 2025: A Closer Look At Results

Updated Category News Views 1306

Pacaso Shows Promising First Half Financial Performance Pacaso, the innovative platform for co-owned luxury vacation homes, has recently shared its financial results for the first half of 2025, demonstrating strong stability and improved efficiency despite a challenging broader housing market. The company reported an impressive adjusted gross profit while managing to...

Continue Reading